▁The 3.169921875
▁study 7.11328125
▁was 2.720703125
▁conducted 1.3046875
▁in 1.40234375
▁the 1.9912109375
▁form 5.5625
▁of 0.0129852294921875
▁collection 9.78125
▁and 1.3642578125
▁analysis 0.666015625
▁of 0.041778564453125
▁statistical 3.03125
▁data 0.36767578125
. 2.28515625
▁Part 7.34375
icip 0.5615234375
ants 0.1519775390625
▁were 0.826171875
▁rec 5.296875
ru 0.006877899169921875
ited 0.001201629638671875
▁for 4.5234375
▁six 7.47265625
▁months 0.475830078125
▁at 3.80078125
▁two 2.87890625
▁major 4.95703125
▁pain 8.3671875
▁relief 4.6484375
▁cent 1.13671875
ers 0.58349609375
▁in 0.481689453125
▁Israel 4.91015625
. 0.6318359375
▁The 1.3046875
▁research 3.54296875
ers 1.93359375
▁used 2.337890625
▁The 7.73046875
▁De 6.57421875
pression 0.369873046875
▁Module 7.078125
▁of 0.5703125
▁the 0.2081298828125
▁Pat 3.857421875
ient 0.0161285400390625
▁Health 0.07470703125
▁Question 0.0114593505859375
naire 0.0262603759765625
▁and 3.927734375
▁the 0.7421875
▁General 3.87109375
ized 1.8232421875
▁An 0.038421630859375
x 0.00128936767578125
iety 0.00036978721618652344
▁Dis 0.2822265625
order 0.027557373046875
▁Sc 1.5908203125
ale 0.0028285980224609375
▁to 1.18359375
▁interview 6.609375
▁participants 2.5625
, 3.37890625
▁evaluate 6.30859375
▁their 0.837890625
▁answers 4.94921875
, 0.7138671875
▁and 0.07733154296875
▁conduct 5.16015625
▁the 2.30859375
▁study 1.505859375
. 0.07989501953125
▁To 5.7890625
▁specifically 9.3671875
▁evaluate 2.07421875
▁and 4.81640625
▁compare 2.080078125
▁the 0.72314453125
▁prob 10.1796875
abilities 0.2322998046875
▁of 0.166748046875
▁de 1.6083984375
pression 0.088134765625
▁or 4.12109375
▁anx 0.239990234375
iety 0.0005559921264648438
▁among 1.923828125
▁the 1.8427734375
▁diverse 7.4765625
▁groups 1.1357421875
, 1.041015625
▁the 0.60302734375
▁study 2.80859375
▁used 1.3935546875
▁multiple 4.91015625
▁log 0.29638671875
istic 0.022674560546875
▁regression 0.2235107421875
▁analysis 1.1396484375
▁and 2.80078125
▁chose 8.8671875
▁medical 7.75
▁mar 3.12890625
iju 0.002590179443359375
ana 1.1205673217773438e-05
▁as 1.04296875
▁the 0.54443359375
▁control 3.77734375
▁group 0.88623046875
. 0.31640625
<0x0A> 0.4404296875
There 5.16015625
▁is 2.15234375
▁currently 4.83984375
▁a 0.9306640625
▁severe 5.88671875
▁lack 1.76953125
▁of 0.0190582275390625
▁information 2.6171875
▁about 1.6572265625
▁the 0.422607421875
▁effects 2.142578125
▁of 0.109619140625
▁op 6.5546875
i 3.615234375
ates 0.004497528076171875
. 4.26171875
▁They 5.2109375
▁manage 9.015625
▁pain 1.939453125
▁successfully 5.765625
, 0.93017578125
▁but 0.210205078125
▁the 2.595703125
▁past 8.75
▁few 1.2236328125
▁dec 1.2099609375
ades 1.2993812561035156e-05
▁indicated 8.4453125
▁the 2.455078125
▁growing 3.52734375
▁concern 3.03125
▁regarding 2.892578125
▁op 2.3125
iate 0.6513671875
▁ab 1.451171875
use 0.0118255615234375
▁in 3.474609375
▁forms 8.90625
▁of 0.36328125
▁over 2.80078125
d 0.07916259765625
ose 0.25634765625
▁and 0.89599609375
▁add 0.71728515625
iction 0.0170135498046875
. 0.11798095703125
▁A 4.12890625
▁more 4.81640625
▁manage 8.8515625
able 0.0007014274597167969
▁and 1.65234375
▁sa 1.78515625
fer 4.3272972106933594e-05
▁alternative 1.0966796875
▁might 4.9609375
▁be 0.30859375
▁medical 1.1484375
▁mar 0.11572265625
iju 0.00042891502380371094
ana 3.063678741455078e-05
. 0.640625
▁However 3.947265625
, 0.006618499755859375
▁the 1.669921875
▁legal 4.1171875
▁status 1.0283203125
▁and 2.890625
▁novel 10.375
ty 0.1376953125
▁of 0.10589599609375
▁this 1.998046875
▁drug 1.955078125
▁do 4.97265625
▁not 0.040191650390625
▁allow 0.73876953125
▁finding 8.1640625
▁a 2.5
▁large 3.0078125
▁number 1.0517578125
▁of 0.004123687744140625
▁studies 1.12109375
▁on 1.83984375
▁its 1.05078125
▁effect 2.19140625
iveness 0.2197265625
. 0.71630859375
▁Specifically 8.125
, 0.1329345703125
▁it 3.076171875
▁concerns 5.953125
▁the 0.8515625
▁emot 7.58984375
ional 0.0127410888671875
▁condition 4.88671875
▁of 0.31787109375
▁patients 0.91796875
▁experien 6.5546875
cing 1.8715858459472656e-05
▁chron 0.775390625
ic 0.0002989768981933594
▁pain 0.0645751953125
. 0.369873046875
▁This 2.7421875
▁research 2.560546875
▁paper 4.44140625
▁a 2.0703125
ims 0.00021445751190185547
▁to 0.0980224609375
▁analyze 3.09375
▁levels 9.265625
▁of 0.048919677734375
▁de 0.437255859375
pression 0.020721435546875
▁and 0.1922607421875
▁anx 0.0274658203125
iety 0.0003376007080078125
▁among 0.73388671875
▁people 2.76953125
▁receiving 3.71875
▁ther 5.6484375
apy 0.049591064453125
▁by 4.37109375
▁comparing 9.3515625
▁the 1.861328125
▁effects 3.337890625
▁of 0.040863037109375
▁ph 5.96875
arma 0.302490234375
ce 0.0092926025390625
ut 0.00022089481353759766
ical 0.0185089111328125
▁op 1.01171875
io 2.546875
ids 0.11688232421875
▁and 0.54052734375
▁MM 5.48828125
. 2.177734375
<0x0A> 0.288818359375
Chr 5.11328125
onic 0.00615692138671875
▁pain 0.1392822265625
▁is 0.87353515625
▁still 6.02734375
▁considered 2.9765625
▁to 2.0703125
▁be 0.052764892578125
▁an 2.75
▁extreme 6.40625
▁issue 3.548828125
▁among 2.9609375
▁at 9.3203125
▁least 0.141357421875
▁ 0.33984375
8 3.794921875
% 1.703125
▁of 0.05267333984375
▁the 0.60400390625
▁residents 7.25
▁of 0.371337890625
▁progress 12.0546875
ive 0.1129150390625
▁countries 0.50439453125
. 0.4638671875
▁The 1.96875
▁introduction 7.25390625
▁of 0.0261688232421875
▁the 3.126953125
▁study 5.4765625
▁describes 5.5078125
▁the 0.5400390625
▁apparent 9.390625
▁link 3.95703125
▁between 0.080078125
▁pain 2.119140625
▁and 0.396240234375
▁dem 9.09375
oral 1.7353515625
ization 0.060760498046875
. 0.91162109375
▁Chron 4.21875
ic 0.00518035888671875
▁pain 0.140380859375
▁is 1.50390625
▁always 5.3984375
▁accompanied 1.6298828125
▁by 0.042083740234375
▁negative 3.98046875
▁emot 0.46533203125
ional 1.1376953125
▁experiences 3.048828125
▁and 2.2109375
▁blocks 11.28125
▁a 2.921875
▁person 0.685546875
’ 0.62646484375
s 0.0011491775512695312
▁ability 1.1318359375
▁to 0.0200653076171875
▁receive 6.4453125
▁joy 3.732421875
▁and 1.3759765625
▁satisfaction 2.375
▁from 0.75244140625
▁life 0.7080078125
. 0.1728515625
▁The 1.8076171875
▁research 2.2578125
▁investig 6.6640625
ates 0.419677734375
▁the 0.50732421875
▁development 6.6875
▁of 0.0654296875
▁de 0.60986328125
pression 0.1064453125
▁and 0.318115234375
▁anx 0.05419921875
iety 0.000507354736328125
▁among 1.0556640625
▁patients 1.177734375
▁receiving 2.220703125
▁ph 2.853515625
arma 0.0867919921875
ce 0.0021419525146484375
ut 1.0251998901367188e-05
ical 0.004241943359375
▁op 0.60009765625
io 0.2958984375
ids 0.129150390625
▁and 0.78125
▁medical 0.94873046875
▁mar 0.07684326171875
iju 0.00029349327087402344
ana 2.396106719970703e-05
▁( 3.201171875
MM 0.233154296875
) 1.205078125
▁as 1.642578125
▁severe 10.1328125
▁pain 0.58544921875
kill 3.0546875
ers 0.00019121170043945312
. 0.1441650390625
▁It 3.13671875
▁comp 3.96484375
ares 0.004482269287109375
▁the 0.48193359375
▁effic 4.6796875
acy 0.005474090576171875
▁of 0.25
▁pres 6.8046875
cri 2.294921875
ptions 0.98388671875
▁and 1.2880859375
▁exam 4.421875
ines 0.0051727294921875
▁the 0.5107421875
▁possibility 3.630859375
▁of 0.102783203125
▁post 8.6015625
- 0.59716796875
tre 1.6279296875
at 0.001682281494140625
ment 0.00403594970703125
▁de 1.1591796875
pression 0.035980224609375
. 1.7802734375
<0x0A> 0.449951171875
The 0.70166015625
▁question 6.9765625
na 2.09375
ires 0.00018978118896484375
▁used 1.478515625
▁different 9.2890625
▁variable 9.7890625
▁measures 3.712890625
▁to 1.228515625
▁collect 3.013671875
▁information 1.921875
. 1.3427734375
▁For 3.193359375
▁example 0.61669921875
, 0.0029239654541015625
▁it 4.140625
▁included 1.537109375
▁compreh 9.0
ensive 0.08258056640625
▁so 5.265625
cio 0.00045752525329589844
- 0.252685546875
dem 0.089599609375
ographic 0.059967041015625
▁data 0.85498046875
: 5.1640625
▁gender 1.884765625
, 0.05853271484375
▁age 0.28857421875
, 0.0265655517578125
▁country 4.0078125
, 2.6484375
▁type 4.28515625
▁of 0.07196044921875
▁residence 3.736328125
▁( 2.20703125
urban 0.70751953125
/ 1.4765625
r 0.1597900390625
ural 0.0009675025939941406
), 0.195068359375
▁years 5.8203125
▁of 0.171142578125
▁education 0.64697265625
, 0.105712890625
▁and 1.212890625
▁employ 2.236328125
ment 0.0015783309936523438
▁status 0.78662109375
. 0.126953125
▁Pat 5.19140625
ients 0.13037109375
▁were 1.3701171875
▁also 1.0263671875
▁asked 0.5556640625
▁about 0.85693359375
▁their 0.810546875
▁medical 2.232421875
▁history 0.479248046875
▁over 8.5859375
▁the 0.0677490234375
▁years 4.75
▁and 1.6640625
▁the 1.390625
▁current 3.083984375
▁presence 5.0625
▁of 0.0775146484375
▁any 2.1875
▁severe 4.26171875
▁dise 2.068359375
ases 8.761882781982422e-05
▁such 4.34765625
▁as 0.0014667510986328125
▁heart 2.623046875
▁failure 1.9404296875
, 0.322021484375
▁di 1.5888671875
ab 0.0010089874267578125
etes 0.002902984619140625
, 0.0836181640625
▁ar 3.982421875
th 0.1641845703125
rit 0.023895263671875
is 0.004657745361328125
, 0.030487060546875
▁and 1.359375
▁so 2.556640625
▁on 0.135009765625
. 0.02569580078125
▁The 1.353515625
▁third 6.30078125
▁measure 3.78125
▁of 2.646484375
▁the 0.5712890625
▁question 0.84765625
naire 0.2115478515625
▁was 1.1484375
▁indicated 11.0234375
▁by 1.2568359375
▁information 6.5546875
▁on 1.974609375
▁any 5.328125
▁twelve 14.0234375
- 0.1492919921875
month 0.1513671875
▁and 5.046875
▁lifetime 0.71728515625
▁drug 3.53125
▁and 1.9013671875
▁alco 0.1402587890625
hol 6.258487701416016e-05
▁consumption 4.25390625
. 0.364013671875
▁In 3.60546875
▁addition 0.7119140625
, 0.1607666015625
▁the 0.83544921875
▁record 10.09375
▁included 1.2646484375
▁a 2.763671875
▁pain 4.24609375
▁measurement 4.7265625
▁scale 1.0146484375
▁from 4.12109375
▁ 0.5078125
0 0.32080078125
▁to 0.1988525390625
▁ 0.007038116455078125
1 0.06591796875
0 0.0297393798828125
▁to 3.40234375
▁evaluate 1.6103515625
▁dis 6.09375
com 0.129150390625
fort 0.0003840923309326172
▁feelings 8.1015625
▁during 3.890625
▁the 0.3095703125
▁last 1.00390625
▁month 1.6455078125
. 0.1783447265625
<0x0A> 0.71484375
This 4.2578125
▁type 5.23046875
▁of 0.00550079345703125
▁study 1.74609375
▁is 1.2998046875
▁the 4.04296875
▁most 1.3291015625
▁reve 8.4140625
aling 0.00043964385986328125
▁and 1.5517578125
▁inclus 6.4765625
ive 0.0005583763122558594
, 3.216796875
▁as 1.5390625
▁it 0.2413330078125
▁contains 4.34375
▁direct 6.03125
▁responses 4.76171875
▁from 0.54541015625
▁a 3.48828125
▁large 0.9638671875
▁number 0.51708984375
▁of 0.0017948150634765625
▁participants 0.93603515625
. 0.37255859375
▁All 5.23828125
▁tools 8.4921875
▁in 4.70703125
▁the 0.689453125
▁form 3.13671875
▁of 0.01605224609375
▁question 0.4892578125
na 0.00788116455078125
ires 1.1682510375976562e-05
▁and 1.7861328125
▁scales 2.51953125
▁have 3.091796875
▁already 4.375
▁been 0.482177734375
▁used 2.26953125
▁and 1.685546875
▁proved 2.423828125
▁their 1.232421875
▁effic 3.162109375
acy 0.0024776458740234375
▁for 3.546875
▁collect 2.689453125
ing 0.0020885467529296875
▁analyt 7.59375
ical 0.055572509765625
▁data 0.25830078125
. 0.314453125
▁It 3.30078125
▁helps 4.140625
▁to 0.62548828125
▁system 6.44921875
at 0.401123046875
ize 0.0012693405151367188
▁and 1.267578125
▁class 4.38671875
ify 0.0011587142944335938
▁distinct 8.4453125
▁kinds 6.32421875
▁of 0.01458740234375
▁information 1.0185546875
▁for 3.669921875
▁subsequent 4.78515625
▁un 8.7734375
comp 4.31640625
licated 0.0199432373046875
▁services 12.390625
. 0.611328125
▁Thus 4.84375
, 0.0028972625732421875
▁research 4.046875
ers 0.257568359375
▁can 1.5234375
▁compare 2.537109375
▁the 1.181640625
▁effects 3.2265625
▁of 0.09649658203125
▁medic 3.87890625
ations 0.60546875
▁on 1.515625
▁patients 1.98828125
▁of 4.3671875
▁diverse 3.212890625
▁age 2.015625
▁groups 2.232421875
, 0.552734375
▁background 3.841796875
s 0.1336669921875
, 0.0130767822265625
▁physical 5.87109375
▁conditions 1.4287109375
, 0.025238037109375
▁emot 6.38671875
ional 0.04327392578125
▁states 1.3310546875
, 0.0278778076171875
▁and 0.2127685546875
▁so 1.408203125
▁on 0.0972900390625
. 0.05316162109375
<0x0A> 0.82373046875
The 0.826171875
▁study 1.7197265625
▁conducted 4.390625
▁a 1.5576171875
▁correlation 6.1796875
▁type 8.7265625
▁of 0.264404296875
▁research 1.291015625
▁with 3.37109375
▁variable 8.0078125
▁measures 0.88134765625
. 1.09375
▁It 1.2431640625
▁evaluated 5.1484375
▁the 0.568359375
▁inter 5.91015625
dep 2.318359375
end 0.0001277923583984375
ence 0.007198333740234375
▁of 0.673828125
▁various 3.294921875
▁factors 0.8798828125
▁that 2.802734375
▁affected 3.755859375
▁the 0.3564453125
▁physical 6.40625
▁and 0.288330078125
▁emot 0.53076171875
ional 0.0001302957534790039
▁condition 1.576171875
▁of 0.040924072265625
▁patients 0.841796875
▁experien 3.310546875
cing 2.0265579223632812e-06
▁chron 0.370361328125
ic 0.00020563602447509766
▁pain 0.029022216796875
. 0.1046142578125
▁For 3.068359375
▁example 0.332763671875
, 0.0006089210510253906
▁the 1.123046875
▁survey 5.01953125
▁showed 3.6015625
▁that 0.66015625
▁the 1.8408203125
▁ratio 7.18359375
▁of 0.1231689453125
▁female 2.984375
▁patients 1.08203125
▁was 1.0947265625
▁remark 8.3203125
ably 0.00010120868682861328
▁higher 0.17724609375
▁in 3.416015625
▁the 1.298828125
▁op 3.29296875
i 2.2265625
ates 0.0096435546875
▁group 0.12109375
▁compared 2.296875
▁to 0.08203125
▁the 0.63720703125
▁MM 0.2340087890625
▁group 0.6259765625
. 0.1846923828125
▁In 2.779296875
▁turn 4.6328125
, 0.0006704330444335938
▁people 4.44921875
▁on 5.25
▁op 2.31640625
i 0.3330078125
ates 0.0018854141235351562
▁were 0.958984375
▁more 1.4462890625
▁likely 0.2054443359375
▁to 0.02728271484375
▁report 3.33984375
▁major 6.453125
▁de 1.2568359375
press 0.99560546875
ive 0.00519561767578125
▁dis 0.80078125
orders 1.24609375
. 1.7880859375
<0x0A> 2.146484375
Part 5.37109375
icip 0.1483154296875
ants 0.0474853515625
▁were 1.5234375
▁rec 1.775390625
ru 0.00021409988403320312
ited 0.00016391277313232422
▁for 0.607421875
▁six 0.05780029296875
▁months 0.0019273757934570312
▁at 0.1463623046875
▁two 0.03619384765625
▁major 0.04345703125
▁pain 0.0233612060546875
▁relief 0.0291900634765625
▁cent 0.00655364990234375
ers 0.0004038810729980469
▁in 0.0287017822265625
▁Israel 0.00634002685546875
. 0.07818603515625
▁All 4.11328125
▁patients 1.3583984375
▁experienced 4.33984375
▁chron 0.8525390625
ic 0.00011396408081054688
▁pain 0.1793212890625
▁for 1.720703125
▁at 0.6435546875
▁least 0.0012979507446289062
▁ 1.8505859375
3 1.7666015625
▁months 0.292236328125
. 1.259765625
▁The 1.2998046875
▁study 1.83203125
▁included 1.8623046875
▁ 0.56689453125
8 3.0859375
9 2.484375
0 2.703125
▁participants 1.453125
, 1.619140625
▁of 2.51171875
▁which 0.4697265625
▁ 0.097412109375
4 1.4169921875
7 2.44140625
4 2.625
▁( 2.87109375
5 0.0986328125
9 5.0390625
%) 0.78369140625
▁were 0.77880859375
▁treated 3.6484375
▁sole 7.62890625
ly 0.00017201900482177734
▁with 0.298583984375
▁op 0.7314453125
io 1.0712890625
ids 0.10833740234375
, 0.55322265625
▁ 1.2060546875
3 1.20703125
2 2.275390625
9 2.447265625
▁( 0.049072265625
4 2.50390625
1 1.11328125
%) 0.054840087890625
▁were 1.51171875
▁treated 0.5859375
▁with 0.337890625
▁MM 0.85888671875
, 0.25048828125
▁and 0.08990478515625
▁ 0.240966796875
7 1.7900390625
7 2.51953125
▁( 0.11749267578125
8 1.9775390625
. 0.841796875
6 2.501953125
%) 0.062744140625
▁acquired 10.4140625
▁both 0.61669921875
▁( 5.03515625
Fe 9.7734375
ing 1.0263671875
old 0.53857421875
▁et 0.87939453125
▁al 0.0157928466796875
., 0.164794921875
▁ 0.0132293701171875
2 0.00659942626953125
0 0.00014102458953857422
1 0.251953125
7 1.6298828125
). 0.0521240234375
▁The 1.1943359375
▁remaining 7.33984375
▁ten 6.86328125
▁participants 1.212890625
▁who 4.73828125
▁did 2.087890625
▁not 0.004413604736328125
▁receive 2.173828125
▁ph 4.38671875
arma 0.1312255859375
ce 0.0007090568542480469
ut 1.1920928955078125e-06
ical 0.0018787384033203125
▁op 1.61328125
io 0.16259765625
ids 0.022064208984375
▁and 2.5859375
▁medical 1.716796875
▁mar 0.0364990234375
iju 0.0002180337905883789
ana 3.9577484130859375e-05
▁were 0.53515625
▁with 6.734375
dra 0.072509765625
wn 3.0159950256347656e-05
▁from 0.240478515625
▁the 0.16064453125
▁analysis 2.21875
▁in 5.1484375
▁the 0.80517578125
▁research 4.20703125
. 0.732421875
▁Therefore 4.9296875
, 0.005077362060546875
▁it 3.478515625
▁is 1.7001953125
▁not 3.24609375
▁possible 0.94775390625
▁to 0.00508880615234375
▁compreh 6.3828125
ens 0.2216796875
ively 0.010650634765625
▁compare 1.4951171875
▁patients 5.19140625
▁taking 3.78125
▁medic 3.708984375
ations 0.439697265625
▁with 1.296875
▁those 0.984375
▁who 0.71142578125
▁do 1.62109375
▁not 0.00327301025390625
. 0.697265625
<0x0A> 0.61181640625
Am 6.0078125
ong 0.0108489990234375
▁all 2.1640625
▁participants 0.951171875
▁in 3.455078125
▁the 0.1380615234375
▁study 0.60009765625
, 0.0445556640625
▁ 0.7392578125
4 1.8701171875
2 2.26953125
. 1.4189453125
2 2.248046875
% 0.046905517578125
▁suffered 4.23046875
▁from 0.04290771484375
▁de 1.779296875
pression 0.16064453125
, 0.8154296875
▁and 1.0048828125
▁ 0.10247802734375
3 1.3046875
7 2.365234375
% 2.509765625
▁experienced 1.986328125
▁excess 7.28515625
ive 0.0246124267578125
▁anx 0.1904296875
iety 0.001384735107421875
. 0.31298828125
▁The 1.431640625
▁pl 11.0078125
ur 0.53125
ality 0.0006017684936523438
▁of 0.1136474609375
▁de 2.818359375
press 1.6455078125
ive 0.05126953125
▁dis 1.859375
orders 0.0745849609375
▁among 2.845703125
▁patients 1.138671875
▁in 2.81640625
▁the 0.2484130859375
▁op 0.724609375
i 0.37841796875
ates 0.0010156631469726562
, 8.65625
▁medical 3.0703125
▁mar 0.02264404296875
iju 0.0006456375122070312
ana 9.298324584960938e-06
, 0.122314453125
▁and 0.07977294921875
▁mixed 1.669921875
▁OP 11.34375
MM 4.34375
▁groups 0.49462890625
▁number 9.109375
ed 0.0165252685546875
▁ 0.150390625
5 1.9482421875
7 2.6484375
. 0.6240234375
1 2.48046875
%, 0.2099609375
▁ 0.0036487579345703125
2 2.115234375
2 2.607421875
. 0.1163330078125
3 2.275390625
%, 0.047637939453125
▁and 0.0450439453125
▁ 0.0015974044799804688
5 2.1953125
1 2.1328125
. 0.1790771484375
4 1.67578125
%, 0.1317138671875
▁respectively 0.017120361328125
. 0.2083740234375
▁The 1.3720703125
▁pl 3.681640625
ur 0.01016998291015625
ality 1.2159347534179688e-05
▁of 0.0245819091796875
▁anx 0.460693359375
iety 0.01629638671875
▁contained 10.734375
▁ 0.2396240234375
4 1.140625
8 2.3671875
. 0.1783447265625
4 2.203125
% 1.9287109375
▁among 2.37890625
▁OP 5.13671875
▁patients 6.0078125
, 0.287353515625
▁ 0.0931396484375
2 1.0029296875
1 2.498046875
. 0.12005615234375
5 2.0625
% 0.0269927978515625
▁among 0.477783203125
▁MM 0.10302734375
▁patients 0.46240234375
, 0.016571044921875
▁and 0.0146331787109375
▁ 0.0247955322265625
3 1.326171875
8 1.9541015625
. 0.1295166015625
7 2.404296875
% 0.01165771484375
▁among 0.20458984375
▁OP 2.44140625
MM 0.1588134765625
▁participants 3.11328125
. 0.19775390625
▁Pat 5.3671875
ients 0.0214385986328125
▁who 1.8974609375
▁took 2.431640625
▁strong 10.1328125
▁op 0.91796875
i 0.90283203125
ates 0.0031604766845703125
▁were 1.408203125
▁t 10.2109375
ended 1.0478515625
▁to 0.008880615234375
▁place 10.0546875
▁their 2.056640625
▁pain 1.3955078125
▁on 1.7744140625
▁a 0.5546875
▁scale 1.6318359375
▁of 0.3359375
▁ 0.10772705078125
9 2.810546875
▁to 2.080078125
▁ 0.011566162109375
1 0.0046234130859375
0 0.007843017578125
▁( 2.64453125
Fe 1.8681640625
ing 0.0032367706298828125
old 0.00046706199645996094
▁et 0.01448822021484375
▁al 0.0013751983642578125
., 0.01154327392578125
▁ 0.0011463165283203125
2 0.0001996755599975586
0 3.540515899658203e-05
1 0.0010986328125
7 0.00527191162109375
). 0.01065826416015625
▁They 3.904296875
▁were 1.857421875
▁also 0.9345703125
▁an 9.75
gu 5.1953125
ished 0.07073974609375
▁em 6.07421875
otion 0.0005931854248046875
ally 0.0004763603210449219
▁and 1.11328125
▁react 7.921875
ed 0.02044677734375
▁rad 9.1796875
ically 0.0010709762573242188
▁neg 5.3203125
atively 0.0010967254638671875
▁to 0.1746826171875
▁almost 6.0546875
▁all 1.373046875
▁survey 4.578125
▁questions 0.31103515625
. 0.309814453125
▁Pat 3.734375
ients 0.0051116943359375
▁who 1.2724609375
▁took 1.732421875
▁only 4.25390625
▁MM 0.398681640625
▁or 2.734375
▁mixed 2.66015625
▁medic 1.45703125
ations 0.1885986328125
▁course 13.8125
▁had 2.541015625
▁a 1.4140625
▁significantly 2.984375
▁more 3.359375
▁stable 3.443359375
▁emot 0.98974609375
ional 0.0008687973022460938
▁state 0.52197265625
▁and 1.3310546875
▁cop 6.63671875
ed 0.019989013671875
▁with 0.38232421875
▁pain 0.92626953125
▁more 1.7333984375
▁manage 6.66796875
able 1.564453125
. 0.329345703125
<0x0A> 0.29345703125
The 0.896484375
▁analysis 3.90625
▁of 0.80029296875
▁any 9.0
▁human 7.5
▁reaction 4.89453125
▁has 4.85546875
▁a 1.7001953125
▁high 3.12890625
▁potential 3.380859375
▁of 2.5703125
▁subject 2.951171875
iveness 3.8203125
▁and 1.3515625
▁bias 1.69140625
, 2.67578125
▁especially 1.8662109375
▁regarding 3.810546875
▁people 4.65625
▁in 3.546875
▁severe 2.5
▁pain 0.8232421875
▁and 2.4765625
▁un 5.56640625
stable 0.79736328125
▁emot 0.482177734375
ional 0.138916015625
▁condition 2.453125
. 0.0501708984375
▁Perhaps 7.7109375
▁some 4.390625
▁patients 1.6044921875
▁tend 5.1015625
▁to 0.011810302734375
▁ex 2.0546875
agger 0.011138916015625
ate 0.0016651153564453125
▁their 0.87060546875
▁de 3.814453125
press 1.0849609375
ive 0.040435791015625
▁state 2.6640625
▁or 1.822265625
▁vice 6.51953125
▁vers 0.00848388671875
a 3.814697265625e-06
, 1.19921875
▁de 7.03125
- 2.259765625
emph 0.478759765625
as 0.0028591156005859375
ize 0.075927734375
▁serious 6.4609375
▁difficulties 5.375
. 0.8837890625
▁Because 6.671875
▁the 2.392578125
▁survey 2.962890625
▁responses 6.5390625
▁were 1.3046875
▁thoroughly 9.2421875
▁anonymous 2.681640625
, 0.247802734375
▁the 1.6123046875
▁research 0.91943359375
ers 0.231689453125
▁were 2.8828125
▁unable 1.375
▁to 0.0013074874877929688
▁carefully 7.38671875
▁analyze 2.62109375
▁each 2.578125
▁patient 2.134765625
’ 0.521484375
s 0.0005068778991699219
▁reaction 3.712890625
▁and 1.2958984375
▁compare 3.3125
▁it 0.95947265625
▁to 0.79833984375
▁the 1.0
▁actual 4.0859375
▁states 8.234375
▁of 0.78955078125
▁condition 7.5546875
. 0.315673828125
▁More 6.42578125
▁accurate 2.89453125
▁answers 4.22265625
▁could 1.7861328125
▁be 0.68017578125
▁obtained 0.97998046875
▁by 1.4375
▁professional 5.734375
▁psych 1.166015625
olog 0.377685546875
ists 0.0008006095886230469
▁via 7.21875
▁personal 2.751953125
▁communication 3.783203125
▁and 1.8740234375
▁behavior 6.12890625
al 0.28564453125
▁analysis 2.140625
. 0.253173828125
▁However 2.716796875
, 0.00022041797637939453
▁this 1.54296875
▁method 2.345703125
▁of 2.318359375
▁research 1.5234375
▁is 0.97607421875
▁way 6.5078125
▁more 0.8310546875
▁resource 4.578125
- 0.30810546875
int 1.228515625
ensive 0.021942138671875
▁and 0.390625
▁energy 10.515625
- 0.101318359375
consum 0.320068359375
ing 0.002750396728515625
. 0.65576171875
<0x0A> 0.552734375
One 4.62109375
▁of 0.254150390625
▁the 0.0030517578125
▁major 2.640625
▁limitations 1.9208984375
▁is 2.771484375
▁the 0.4716796875
▁ins 4.58203125
u 0.0648193359375
fficient 0.0689697265625
ly 3.69921875
▁high 3.1328125
▁response 3.5703125
▁rate 0.094970703125
, 2.76953125
▁ 4.35546875
5 1.5244140625
7 3.150390625
% 2.046875
▁instead 6.15234375
▁of 0.0021839141845703125
▁ 0.474365234375
7 1.9306640625
0 0.34765625
% 1.392578125
▁( 1.994140625
Fe 0.4951171875
ing 0.0014057159423828125
old 0.0002460479736328125
▁et 0.00914764404296875
▁al 0.0003132820129394531
., 0.0057525634765625
▁ 0.0007538795471191406
2 0.00010645389556884766
0 3.254413604736328e-05
1 0.0003495216369628906
7 0.00308990478515625
). 0.01036834716796875
▁It 1.6064453125
▁can 3.25390625
▁be 0.81396484375
▁fairly 8.3203125
▁explained 1.4423828125
▁by 0.202880859375
▁the 0.265869140625
▁weak 7.5
▁focus 7.0703125
▁of 0.67041015625
▁respond 5.4375
ents 0.10089111328125
▁who 3.51171875
▁have 3.8828125
▁overcome 8.5234375
▁severe 1.9521484375
▁pain 0.497802734375
▁sens 7.8359375
ations 0.2099609375
▁and 0.9033203125
▁de 4.8515625
press 0.861328125
ive 0.0472412109375
▁episodes 2.140625
. 0.46923828125
▁It 2.60546875
▁is 0.712890625
▁not 2.572265625
▁clear 3.59375
▁how 1.9306640625
▁to 3.33984375
▁use 5.44140625
▁these 2.97265625
▁statistics 4.08203125
, 3.14453125
▁as 0.7646484375
▁they 1.921875
▁still 5.16015625
▁may 4.67578125
▁be 1.39453125
▁relevant 5.16796875
▁for 1.7939453125
▁the 1.791015625
▁overall 4.546875
▁analysis 2.462890625
. 0.89453125
